STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity

Cancer Letters
Jianwen PeiJunmin Quan

Abstract

Cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is a key regulator in innate immunity and has emerged as a promising drug target in cancer treatment, but the utility of this pathway in therapeutic development is complicated by its dichotomous roles in tumor development and immunity. The activation of the STING pathway and the induced antitumor immunity could be attenuated by the feedback activation of IL-6/STAT3 pathway. Here we reported that STAT3 inhibition significantly enhanced the intensity and duration of STING signaling induced by the STING agonist c-diAM(PS)2. Such sensitization effect of STAT3 inhibition on STING signaling depended on STING rather than cGAS, which was mediated by simultaneously upregulating the positive modulators and downregulating the negative modulators of the STING pathway. Furthermore, the combination treatment with the STAT3 inhibitor and STING agonist markedly regressed tumor growth in syngeneic mice by increasing CD8+ T cells and reducing regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment. Our work provides a rationale for the combination of STAT3 inhibitors and STING agonists in cancer immunotherapy.

Citations

Apr 15, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nicole A WilskiChristopher M Snyder
Sep 26, 2020·Molecular Cancer·Sailan ZouXianghui Fu
Dec 2, 2020·Journal of Cellular and Molecular Medicine·Lehe YangWanle Hu
Jan 16, 2021·Drug Discovery Today·Sandeep KumarAjay Rana
Dec 1, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Huashan DuManhua Cui
Feb 17, 2021·Cellular Immunology·Vera M KhoGosse J Adema
Feb 26, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Shan-Shan ZouJingtao Chen
Mar 20, 2021·Pulmonary Circulation·Andrew J BryantLei Jin
Sep 9, 2020·The Journal of Allergy and Clinical Immunology·Ana CopaescuJason A Trubiano
Apr 2, 2021·Scientific Reports·Manuel Adrian SuterY L Zhang
Jun 24, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Masaya YokotaBritta Maurer
Jul 25, 2021·International Journal of Molecular Sciences·Bingqing ZhengJian Zhang
Nov 19, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Thomas E BickettSana D Karam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.